Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
about
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysisAlpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis BAflatoxin: a 50-year odyssey of mechanistic and translational toxicologyContribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaSurveillance for Hepatocellular Carcinoma in Patients with NASHEarly Detection of Hepatocellular Carcinoma: How to Screen and Follow up Patients with Liver Cirrhosis According to the GERMAN S3 Guideline?Diagnostic and therapeutic management of hepatocellular carcinomaHepatocellular Cancer: New Kids on the BlockSurveillance for hepatocellular carcinoma.Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Viral hepatitis and hepatocellular carcinoma: etiology and managementDecrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.Managing the changing burden of cancer in Asia.Application of AFP whole blood one-step rapid detection kit in screening for HCC in Qidong.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.Role of surveillance in prevention of hepatocellular carcinoma.Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers.Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.Hepatocellular carcinoma: From diagnosis to treatment.Factors influencing physicians' screening behavior for liver cancer among high-risk patientsHepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.Clinical guideline SEOM: hepatocellular carcinomaLiver Cancer Detection by a Simple, Inexpensive and Effective Immunosensor with Zinc Oxide NanoparticlesElectronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trialEpidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.Use of Biomarkers in Screening for Cancer.Transcriptome analysis of liver cancer: ready for the clinic?Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of ChinaHepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversiesPigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosisProspective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.Liver cancer incidence and mortality in China, 2009
P2860
Q21144594-0D937316-FDF9-4B1A-9DBF-6B366A3D15B9Q24200785-8624CA41-A57D-44EB-B5BC-52962057391AQ24617120-5448C5A4-5FBC-4194-9FBB-CC97A94068D5Q26740332-60EF3A53-066B-4218-AC5C-9EDEDDD903FAQ26747428-38D10891-CC17-4BDE-8CD7-3D26AF793347Q26768466-DCD5FD8E-53F2-4459-8771-DC41A486BC77Q26999043-922BF911-5A9A-474C-904E-7D7FBE44E508Q27022642-DF6244D8-B786-43E8-A5A7-A06BCA70AEF7Q27690269-80F2E622-318B-4645-BE10-EC47172508E4Q30244651-1D7F7DAA-17B9-4D88-ACA8-AED9E30CA06EQ33562288-C6401AEC-14F6-4CB9-9CA4-132F332AF06EQ33593219-FE2F5DDC-7586-4383-A0C2-8352E32A7DCFQ33621640-CB87F101-C25D-4DBC-94F5-AD1FA0D73DD9Q33643009-9120632D-1DC6-4E3F-BC83-B9C73A79860CQ33850070-BEE88B4A-CC8B-4C4B-9311-A8F084714207Q33866448-623F689F-CF1C-44CE-8D51-276EDC2C6AA5Q33935625-A9330223-BA25-4612-A717-A9FFFEDE2BDAQ34064761-70210F12-8A44-4FA8-947E-FA80A46C8FB3Q34137291-31CC5705-425F-46FA-B094-961C6FD6BB34Q34808766-0137FDF3-B88D-4EE7-9405-F222432ABCB0Q34826014-EF41AC4E-E4F0-4F7C-BFBE-55574A902798Q34852702-FFA2B25D-6C36-4EFC-840F-534DAA927C52Q35020474-06528295-9723-4CA7-B971-3565A0748B5AQ35668716-7BC75C5E-5E31-4D30-8400-DFFBD26BA2BDQ35691504-CB40E7D3-FEBB-4DA5-97F1-3E9D631C643FQ36079127-75196130-4B8E-4575-AFCB-71509F7AB8B8Q36229496-272B38FF-19F1-4F37-BB4D-ED1E3EBEB606Q36349931-6A915DB5-A7E2-49AE-B8E0-E1846F02B190Q36400259-01926D35-1E10-4E6C-B2DD-C03188E2DEC6Q36430381-F3BDD32D-1654-4649-ABE4-85B96B3B75ECQ36625726-0B026036-3102-41A0-A559-8D0D5D66638EQ36897895-3D546627-37A4-4FF0-8F5F-806763F3806AQ37155019-031C7401-2D68-4383-B294-44D7986C0013Q37227819-15EFD5A3-AFE6-446D-97A9-EE0AD8CD43FEQ37238789-54CC5E8C-4A75-442A-BAFA-88E02C939A90Q37242795-27C2578F-3033-4C38-8A62-8FC06198F340Q37266376-1C7916FD-A0EA-4B6F-AB31-4A95FF9CB2EAQ37311888-0B1E3F79-4E18-46C5-9C2D-646090BB57ECQ37350320-F147F0BD-1191-4F81-9551-EB1782932FA4Q37354015-E2A7B39D-F09E-43B0-92FD-F68ABF8D0FE5
P2860
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@en
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@nl
type
label
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@en
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@nl
prefLabel
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@en
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@nl
P2093
P1476
Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
@en
P2093
P304
P356
10.1258/096914103771773320
P577
2003-01-01T00:00:00Z